Insider filing · ARWR
Daniel Joseph Apel
Chief Financial Officer
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Daniel Joseph Apel sold $853K of Arrowhead Pharmaceuticals (ARWR)
Executed Apr 22, disclosed Apr 24, 2 days later.
Value, as filed
$853K
11,938 sh across 2 lots
Executed
Apr 22
the trade date, as filed
Disclosed
Apr 24
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DADaniel Joseph Apel (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $853K of ARWR (11,938 sh across 2 lots, as filed), executed Apr 22.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→